147 related articles for article (PubMed ID: 15548526)
21. CCR1 chemokine receptor antagonist.
Saeki T; Naya A
Curr Pharm Des; 2003; 9(15):1201-8. PubMed ID: 12769747
[TBL] [Abstract][Full Text] [Related]
22. A chimeric MIP-1alpha/RANTES protein demonstrates the use of different regions of the RANTES protein to bind and activate its receptors.
Blanpain C; Buser R; Power CA; Edgerton M; Buchanan C; Mack M; Simmons G; Clapham PR; Parmentier M; Proudfoot AE
J Leukoc Biol; 2001 Jun; 69(6):977-85. PubMed ID: 11404385
[TBL] [Abstract][Full Text] [Related]
23. Chapter 12. The use of receptor homology modeling to facilitate the design of selective chemokine receptor antagonists.
Carter PH; Tebben AJ
Methods Enzymol; 2009; 461():249-79. PubMed ID: 19480923
[TBL] [Abstract][Full Text] [Related]
24. Human LZIP binds to CCR1 and differentially affects the chemotactic activities of CCR1-dependent chemokines.
Ko J; Jang SW; Kim YS; Kim IS; Sung HJ; Kim HH; Park JY; Lee YH; Kim J; Na DS
FASEB J; 2004 May; 18(7):890-2. PubMed ID: 15001559
[TBL] [Abstract][Full Text] [Related]
25. Structure modeling of the chemokine receptor CCR5: implications for ligand binding and selectivity.
Paterlini MG
Biophys J; 2002 Dec; 83(6):3012-31. PubMed ID: 12496074
[TBL] [Abstract][Full Text] [Related]
26. Cloning, expression, and functional characterization of cynomolgus monkey (Macaca fascicularis) CC chemokine receptor 1.
Gupta S; Schulz-Maronde S; Kutzleb C; Richter R; Forssmann WG; Kapp A; Forssmann U; Elsner J
J Leukoc Biol; 2005 Nov; 78(5):1175-84. PubMed ID: 16204626
[TBL] [Abstract][Full Text] [Related]
27. Variations in eosinophil chemokine responses: an investigation of CCR1 and CCR3 function, expression in atopy, and identification of a functional CCR1 promoter.
Phillips RM; Stubbs VE; Henson MR; Williams TJ; Pease JE; Sabroe I
J Immunol; 2003 Jun; 170(12):6190-201. PubMed ID: 12794150
[TBL] [Abstract][Full Text] [Related]
28. Design, synthesis, and discovery of a novel CCR1 antagonist.
Naya A; Sagara Y; Ohwaki K; Saeki T; Ichikawa D; Iwasawa Y; Noguchi K; Ohtake N
J Med Chem; 2001 Apr; 44(9):1429-35. PubMed ID: 11311066
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and characterization of fluorescent and photoactivatable MIP-1alpha ligands and interactions with chemokine receptors CCR1 and CCR5.
Zoffmann S; Turcatti G; Galzi J; Dahl M; Chollet A
J Med Chem; 2001 Jan; 44(2):215-22. PubMed ID: 11170631
[TBL] [Abstract][Full Text] [Related]
30. Reversed binding of a small molecule ligand in homologous chemokine receptors - differential role of extracellular loop 2.
Jensen PC; Thiele S; Steen A; Elder A; Kolbeck R; Ghosh S; Frimurer TM; Rosenkilde MM
Br J Pharmacol; 2012 May; 166(1):258-75. PubMed ID: 22050085
[TBL] [Abstract][Full Text] [Related]
31. Discovery of novel non-peptide CCR1 receptor antagonists.
Ng HP; May K; Bauman JG; Ghannam A; Islam I; Liang M; Horuk R; Hesselgesser J; Snider RM; Perez HD; Morrissey MM
J Med Chem; 1999 Nov; 42(22):4680-94. PubMed ID: 10579830
[TBL] [Abstract][Full Text] [Related]
32. Identification of CC chemokine receptor 7 residues important for receptor activation.
Ott TR; Pahuja A; Nickolls SA; Alleva DG; Struthers RS
J Biol Chem; 2004 Oct; 279(41):42383-92. PubMed ID: 15284247
[TBL] [Abstract][Full Text] [Related]
33. Eotaxin-3/CCL26 is a natural antagonist for CC chemokine receptors 1 and 5. A human chemokine with a regulatory role.
Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
J Biol Chem; 2004 May; 279(22):23357-63. PubMed ID: 15039444
[TBL] [Abstract][Full Text] [Related]
34. Identification of the pharmacophore of the CC chemokine-binding proteins Evasin-1 and -4 using phage display.
Bonvin P; Dunn SM; Rousseau F; Dyer DP; Shaw J; Power CA; Handel TM; Proudfoot AEI
J Biol Chem; 2014 Nov; 289(46):31846-31855. PubMed ID: 25266725
[TBL] [Abstract][Full Text] [Related]
35. Identification and characterization of a rat macrophage inflammatory protein-1alpha receptor.
Waller A; Nayee P; Czaplewski LG
J Hematother Stem Cell Res; 2000 Oct; 9(5):703-9. PubMed ID: 11091494
[TBL] [Abstract][Full Text] [Related]
36. Structure function differences in nonpeptide CCR1 antagonists for human and mouse CCR1.
Onuffer J; McCarrick MA; Dunning L; Liang M; Rosser M; Wei GP; Ng H; Horuk R
J Immunol; 2003 Feb; 170(4):1910-6. PubMed ID: 12574358
[TBL] [Abstract][Full Text] [Related]
37. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
[TBL] [Abstract][Full Text] [Related]
38. Exploring a model of a chemokine receptor/ligand complex in an explicit membrane environment by molecular dynamics simulation: the human CCR1 receptor.
Shahlaei M; Madadkar-Sobhani A; Fassihi A; Saghaie L
J Chem Inf Model; 2011 Oct; 51(10):2717-30. PubMed ID: 21910472
[TBL] [Abstract][Full Text] [Related]
39. Ethanol inhibition of N-methyl-D-aspartate receptors is reduced by site-directed mutagenesis of a transmembrane domain phenylalanine residue.
Ronald KM; Mirshahi T; Woodward JJ
J Biol Chem; 2001 Nov; 276(48):44729-35. PubMed ID: 11572853
[TBL] [Abstract][Full Text] [Related]
40. Positive versus negative modulation of different endogenous chemokines for CC-chemokine receptor 1 by small molecule agonists through allosteric versus orthosteric binding.
Jensen PC; Thiele S; Ulven T; Schwartz TW; Rosenkilde MM
J Biol Chem; 2008 Aug; 283(34):23121-8. PubMed ID: 18559339
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
